Mild COVID-19 quickly treated by Zinc lozenges in 4 people – June 6, 2020

Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients

International Journal of Infectious Diseases, online 6 June 2020, https://doi.org/10.1016/j.ijid.2020.06.006
EricFinzi

VitaminDWiki

Items in both categories Zinc and Virus are listed here:

Items in both categories Zinc and Immunity are listed here:

 Download the PDF from VitaminDWiki

Coronavirus 2019 (COVID-19) is a pandemic with substantial mortality and no accepted therapy. We report here on four consecutive outpatients with clinical characteristics (CDC case definition) of and/or laboratory-confirmed COVID-19 who were treated with high dose zinc salt oral lozenges. All four patients experienced significant improvement in objective and symptomatic disease measures after one day of high dose therapy suggesting that zinc therapy was playing a role in clinical recovery. A mechanism for zinc’s effects is proposed based on previously published studies on SARS- CoV-1, and randomized controlled trials assessing zinc shortening of common cold duration. The limited sample size and study design preclude a definitive statement about the effectiveness of zinc as a treatment for COVID-19 but suggest the variables to be addressed to confirm these initial findings in future trials.


Zn(2+) Inhibits Coronavirus and Arterivirus RNA Polymerase Activity in Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture - Nov 2010

 Download the PDF from VitaminDWiki


2208 visitors, last modified 07 Aug, 2020,
Printer Friendly Follow this page for updates